Spasmophilia in children and the anticonvulsant properties of a new Ukrainian preparation containing a pyrimidine derivative
Shapovalova, V.O.; Shapovalov, V.V.
Fiziolohichnyi Zhurnal 44(5-6): 102-105
1998
ISSN/ISBN: 2522-9028 PMID: 9866032 Document Number: 493009
Tablets valcophen, which are containing the pyrimidine's derivative, have an acute anticonvulsive activity. Tablets valcophen and granules phenobarbital for children are having the same activity, which have been marked about lower intensity convulsions, quantity of a lived animals and also lengthening a time of deathing mice. These investigations are showing that tablets valcophen may be used for treatment convulsive state in children.
Document emailed within 1 workday
Related Documents
Kozlovskaia, M.M.; Inozemtsev, A.N.; Nikitin, S.V.; Gochmuradov, A.G.; Iakushev, R.A.; Chabak-Gorbach, R. 1995: Comparison of neurotropic and stress-protective properties of piracetam and the derivative pyrido]1,2-a]pyrimidine Biulleten' Eksperimental'noi Biologii i Meditsiny 119(3): 299-301Yoshimura, Y.; Matsuda, A.; Ueda, T. 1989: Synthesis of 2'-deoxy-6,2'-methano-pyrimidine nucleosides and optical properties of pyrimidine C-cyclonucleosides Nucleic Acids Symposium Series 21: 79-80
Popoviciu, L.; Asgian, B.; Fagarasanu, M.; Dulau, E.; Sandru, E. 1970: Clinical, electroencephalographic and polygraphic studies of sleep in spasmophilia. Relation of spasmophilia to epilepsy, organic diseases of the nervous system, and neuroses Revue Neurologique (Paris) 123(4): 266-267
Szentmiklósi, P.; Marton, S.; Kovács, M.; Gyarmati, L. 1979: The absorption and excretion rates of a new pyrido[1,2-a] pyrimidine derivative (Chinoin 123) in rats Die Pharmazie 34(9): 551-556
Carpentier, P.; Foquin-Tarricone, A.; Bodjarian, N.; Rondouin, G.; Lerner-Natoli, M.; Kamenka, J.M.; Blanchet, G.; Denoyer, M.; Lallement, G. 1994: Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning Neurotoxicology 15(4): 837-851
Shapovalova, V.O.; Mykhaĭlov, V.S.; Shapovalov, V.V. 1999: The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice Fiziolohichnyi Zhurnal 45(3): 114-117
Dubois, B.; Bernard, P.; Farriaux, J.P.; Fontaine, G. 1975: Spasmophilia in children. Diagnostic considerations Archives Francaises de Pediatrie 32(5): 492
Gyires, K.; Fürst, S.; Miklya, I.; Budavari, I.; Knoll, J. 1985: Analysis of the analgesic and anti-inflammatory effects of rimazolium, a pyrido-pyrimidine derivative, compared with that of prostaglandin synthesis inhibitors and morphine Drugs under Experimental and Clinical Research 11(8): 493-500
Serra, M.; Foddi, M.C.; Ghiani, C.A.; Melis, M.A.; Motzo, C.; Concas, A.; Sanna, E.; Biggio, G. 1992: Pharmacology of gamma-aminobutyric acidA receptor complex after the in vivo administration of the anxioselective and anticonvulsant beta-carboline derivative abecarnil Journal of Pharmacology and Experimental Therapeutics 263(3): 1360-1368
Cieplik, J.; Stolarczyk, M.; Pluta, J.; Gubrynowicz, O.; Bryndal, I.; Lis, T.; Mikulewicz, M. 2015: Synthesis and antibacterial properties of pyrimidine derivatives Acta Poloniae Pharmaceutica 72(1): 53-64
Wagner, E.; Poreba, K.; Jakowicz, I.; Balicka, D.; Rutkowska, M.; Kedzierska-Goździk, L.; Szelag, A. 1995: Synthesis and pharmacological properties of derivatives of isoxazolo[4,3-d]pyrimidine. IIi Farmaco 50(3): 183-187
Turkanis, S.A.; Cely, W.; Olsen, D.M.; Karler, R. 1974: Anticonvulsant properties of cannabidiol Research Communications in Chemical Pathology and Pharmacology 8(2): 231-246
Cizmáriková, R.; Racanská, E.; Misíková, E.; Greksáková, O. 1998: Preparation and anticonvulsant activity of new potential beta-adrenoreceptor blockers Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 47(5): 220-224
Ektova, L.V.; Iartseva, I.V.; Khorosheva, E.V.; Ivanova, T.P.; Iavorskaia, N.P.; Mel'nik, S.I. 1995: Synthesis and biological properties of pyrimidine 2'-deoxynucleosides modified by a residue of quinaldic acid Bioorganicheskaia Khimiia 21(8): 625-631
Matosiuk, D.; Tkaczyński, T.; Jagiełło-Wójtowicz, E.; Zebrowska-Lupina, I.; Czuczwar, S.J.; Matuszek, B.; Klenk-Majewska, B.; Danilczuk, Z.; Janusz, W.; Kleinrok, Z. 1992: Synthesis and some central pharmacological properties of new derivatives of 2,3-dihydroimidazo[1,2-a]pyrimidine-6-carboxylic acid Polish Journal of Pharmacology and Pharmacy 44(1): 67-78
Palmer, G.C.; Murray, R.J.; Cramer, C.L.; Stagnitto, M.L.; Knowles, M.K.; Freedman, L.R.; Eismann, M.S.; Mahmood, N.; Balestra, M.; Borrelli, A.R.; Hudzik, T.J.; McCarthy, D.J. 1999: S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties Journal of Pharmacology and Experimental Therapeutics 288(1): 121-132
Hajnsek, F.; Hajnsek, S. 1985: Anticonvulsant properties of clobazam in a group of resistant epileptic patients Lijecnicki Vjesnik 107(3-4): 127-131
Stachowicz, K.J. 1973: Isolation and properties of proteolytic enzymes of streptomyces erythreus. II. Properties of crude enzyme preparation Acta Microbiologica Polonica. Series B: Microbiologia Applicata 5(1): 21-27
Bordin, F.; Marciani, S.; Baccichetti, F.R.; Dall'Acqua, F.; Rodighiero, G. 1975: Studies on the photosensitizing properties of angelicin, an angular furocoumarin forming only monofunctional adducts with the pyrimidine bases of DNA Italian Journal of Biochemistry 24(5): 258-267
Kulikowski, T.; Zawadzki, Z.; Shugar, D.; De Clercq, E. 1981: Pyrimidine arabinofuranosyl nucleosides with 5-substituted long, branched and unsaturated chains: synthesis and antiherpes properties Nucleic Acids Symposium Series 9: 103-106